13F reference period
Q2 2026
Security Snapshot
PALISADE BIO, INC. - Common Stock (PALI) Institutional Ownership
CUSIP: 696389402
13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026
Institutions Reporting
124
Shares (Excl. Options)
173.39M
Full value: 173,385,327 · shares · 30 Jun 2026Price
$2.09
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- PALI on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 173,385,327
- Total 13F value
- $362,410,433
- Portfolio coverage rank
- 0%
- Share change
- +24,064,588
- Value change
- +$53,495,540
- Number of holders
- 124
- Shares outstanding
- 174,337,306
- SEC-reported price per share
- $1.47
- Insider filing price
- $1.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- PALI - PALISADE BIO, INC. - Common Stock is tracked under CUSIP 696389402.
- 124 institutions reported positions in Q2 2026.
- 12 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 95 to 124 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$261.72M
Full value: $261,721,164 · USD · 31 Mar 2026.$362.41M
Full value: $362,410,433 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 124 institutions filings for Q2 2026.
Security key
696389402
13F reference period
Q2 2026
13F holders
124
13D/G owners
12
CIK / CUSIP context first
Open Q2 2026 holders
PALI full holder history
PALISADE BIO, INC. SEC filings
PALISADE BIO, INC. company facts
PALISADE BIO, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 696389402:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
12
Security
PALI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $30,835,838 | +$3,278,888 | 17,620,479 | +12% | RA Capital Management, L.P. | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC | 10% | 0% | $29,184,225 | +$5,677,630 | 15,200,117 | +24% | Perceptive Advisors LLC | 31 Dec 2025 |
| JANUS HENDERSON GROUP PLC | 10% | $27,835,737 | 14,885,421 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| Soleus Capital Master Fund, L.P. | 7.5% | +42% | $25,604,827 | +$7,271,600 | 13,063,687 | +40% | Soleus Capital Master Fund, L.P. | 30 Jun 2026 |
| BlackRock, Inc. | 6% | $21,811,785 | 10,436,760 | BlackRock, Inc. | 30 Jun 2026 | |||
| Octagon Capital Advisors LP | 6.4% | $18,370,364 | 9,567,898 | Octagon Capital Advisors LP | 31 Dec 2025 | |||
| FRANKLIN RESOURCES INC | 6% | $21,358,511 | 9,163,990 | Franklin Resources, Inc. | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $12,144,337 | 8,995,805 | Vanguard Capital Management | 30 Sep 2026 | |||
| AMERIPRISE FINANCIAL INC | 5.3% | $15,244,924 | 8,711,385 | Ameriprise Financial, Inc. | 31 Mar 2026 | |||
| Squadron Capital Management LLC | 3% | -61% | $8,640,000 | -$7,200,000 | 4,500,000 | -45% | Squadron Master Fund LP | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 10% | 0% | $335,053 | +$132,407 | 471,906 | +65% | Armistice Capital, LLC | 31 Mar 2025 |
| Point72 Asset Management, L.P. | 0.2% | -97% | $720,601 | -$17,646,090 | 411,772 | -96% | Point72 Asset Management, L.P. | 31 Mar 2026 |
As of 30 Jun 2026,
124
institutional investors reported holding
shares of
PALISADE BIO, INC. - Common Stock (PALI).
This represents
99%
of the company’s total
outstanding shares.
173.39M
Full value: 173,385,327 · shares · 30 Jun 2026174.34M
Full value: 174,337,306 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
81%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Soleus Capital Management, L.P. | 7.5% | 13,063,687 | 0.94% | $27,303,106 | |
| B Group, Inc. | 6.5% | 11,414,285 | 0% | 14% | $23,855,856 |
| AMERIPRISE FINANCIAL INC | 6.4% | 11,081,434 | -3.7% | 0% | $23,160,197 |
| Jupiter Topco LLC | 6.1% | 10,689,452 | 0% | 0.01% | $22,394,402 |
| BlackRock, Inc. | 6% | 10,436,760 | +456% | 0% | $21,812,829 |
| Octagon Capital Advisors LP | 5.9% | 10,276,317 | 0% | 2% | $21,477,503 |
| PERCEPTIVE ADVISORS LLC | 4.8% | 8,425,065 | -5.6% | 0.27% | $17,608,386 |
| RA CAPITAL MANAGEMENT, L.P. | 4.1% | 7,124,116 | 0% | 0.13% | $14,889,402 |
| FRANKLIN RESOURCES INC | 3.3% | 5,785,189 | 0% | 0% | $12,091,045 |
| Point72 Asset Management, L.P. | 3% | 5,253,403 | +1176% | 0.02% | $10,979,612 |
| Boxer Capital Management, LLC | 2.8% | 4,799,875 | 0% | 0.76% | $10,031,739 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.6% | 4,500,000 | 0% | 0.01% | $9,405,000 |
| Eversept Partners, LP | 2.4% | 4,182,785 | -16% | 0.48% | $8,742,021 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 3,760,485 | +143% | 0% | $7,861,359 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.1% | 3,703,936 | +28% | 0% | $7,741,226 |
| GOLDMAN SACHS GROUP INC | 2.1% | 3,578,020 | -33% | 0% | $7,478,062 |
| FEDERATED HERMES, INC. | 1.8% | 3,136,607 | 0% | 0.01% | $6,555,509 |
| Squadron Capital Management LLC | 1.7% | 3,000,000 | 0% | 2.1% | $6,270,000 |
| Propel Bio Management, LLC | 1.5% | 2,582,388 | +132% | 2.8% | $5,397,191 |
| Vestal Point Capital, LP | 1.4% | 2,500,000 | 0% | 0.12% | $5,225,000 |
| STATE STREET CORP | 1.4% | 2,475,648 | +289% | 0% | $5,174,104 |
| MORGAN STANLEY | 1.4% | 2,474,069 | -46% | 0% | $5,170,803 |
| ORBIMED ADVISORS LLC | 1.3% | 2,333,000 | 0% | 0.09% | $4,875,970 |
| GREAT POINT PARTNERS LLC | 1.3% | 2,284,819 | -33% | 1.1% | $4,775,272 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.3% | 2,257,106 | +30% | 0.68% | $4,717,352 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Headline period
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 5,117,288 | $6,918,959 | +$74,935 | $1.35 | 19 |
| 2026 Q2 | 173,385,327 | $362,410,433 | +$53,495,540 | $2.09 | 124 |
| 2026 Q1 | 149,487,450 | $261,721,164 | +$17,397,309 | $1.75 | 95 |
| 2025 Q4 | 135,909,594 | $319,442,849 | +$306,785,730 | $2.35 | 87 |
| 2025 Q3 | 119,592 | $102,817 | +$30,259 | $0.86 | 12 |
| 2025 Q2 | 84,610 | $57,544 | -$119,036 | $0.68 | 11 |
| 2025 Q1 | 260,593 | $176,598 | -$26,884 | $0.68 | 11 |
| 2024 Q4 | 199,223 | $328,718 | +$210,668 | $1.65 | 9 |
| 2024 Q3 | 62,098 | $220,448 | +$113,672 | $3.55 | 8 |
| 2024 Q2 | 30,078 | $135,352 | +$135,352 | $4.50 | 7 |